Primary Cell Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the primary cell market looks promising with opportunities in life science research companies and research institutes. The global primary cell market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are increasing cancer research and rapid growth in the biotechnology and biopharmaceutical industries.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global primary cell market report, please download the report brochure.
In this market, human primary cell is the largest type of primary cell, whereas life science research companies is the largest end user. Growth in various segments of the primary cell market are given below:
The study includes trends and forecast for the global primary cell market by origin, type, end user, and region as follows:
By Origin [Value ($ Million) shipment analysis for 2014 – 2025]:
Lucintel forecasts that the human primary cell segment will remain the fastest growing type market over the forecast period due to high adoption of human primary cells in the development of novel cancer therapies.
Within this market, life science research companies will remain the highest growing end user segment by over the forecast period due to the increasing adoption of primary cells in cell-based experiments and cancer research in life science research companies as well as the increasing number of R&D facilities.
North America will remain the largest region over the forecast period due to increasing number of players launching new human primary cells for research, expansion of pharmaceutical and biotechnology industries, and increasing prevalence of cancer in the region.
Features of the Global Primary Cell Market
Q.1 What are some of the most promising potential, high-growth opportunities for the global primary cell market by origin (hematopoietic cells, skin cells, gastrointestinal cells, liver cells, lung cells, renal cells, heart cells, skeletal & muscle cells, and other primary cells), type (human primary cells and animal primary cells), end user (life science research companies and research institutes), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global primary cell market?
Q.5 What are the business risks and threats to the global primary cell market?
Q.6 What are the emerging trends in this primary cell market and the reasons behind them?
Q.7 What are some changing demands of customers in this primary cell market?
Q.8 What are the new developments in this primary cell market? Which companies are leading these developments?
Q.9 Who are the major players in this primary cell market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this primary cell market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global primary cell market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Origin (Hematopoietic Cells, Skin Cells, Gastrointestinal Cells, Liver Cells, Lung Cells, Renal Cells, Heart Cells, Skeletal & Muscle Cells, and Other Primary Cells), Type (Human Primary Cells and Animal Primary Cells), and End User (Life Science Researcharmacogenetics, and Other Applications)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the primary cell market looks promising with opportunities in life science research companies and research institutes. The global primary cell market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are increasing cancer research and rapid growth in the biotechnology and biopharmaceutical industries.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global primary cell market report, please download the report brochure.
In this market, human primary cell is the largest type of primary cell, whereas life science research companies is the largest end user. Growth in various segments of the primary cell market are given below:
The study includes trends and forecast for the global primary cell market by origin, type, end user, and region as follows:
By Origin [Value ($ Million) shipment analysis for 2014 – 2025]:
- Hematopoietic Cells
- Skin Cells
- Gastrointestinal Cells
- Liver Cells
- Lung Cells
- Renal Cells
- Heart Cells
- Skeletal & Muscle Cells
- Other Primary Cells
- Human Primary Cells
- Animal Primary Cells
- Life Science Research Companies
- Research Institutes
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Spain
- German
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Lucintel forecasts that the human primary cell segment will remain the fastest growing type market over the forecast period due to high adoption of human primary cells in the development of novel cancer therapies.
Within this market, life science research companies will remain the highest growing end user segment by over the forecast period due to the increasing adoption of primary cells in cell-based experiments and cancer research in life science research companies as well as the increasing number of R&D facilities.
North America will remain the largest region over the forecast period due to increasing number of players launching new human primary cells for research, expansion of pharmaceutical and biotechnology industries, and increasing prevalence of cancer in the region.
Features of the Global Primary Cell Market
- Market Size Estimates: Global primary cell market size estimation in terms of value ($M) shipment.
- Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
- Segmentation Analysis: Global primary cell market size by various segments, such as origin, type, and end user in terms of value.
- Regional Analysis: Global primary cell market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different origin, type, end user, and region for the global primary cell market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global primary cell market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q.1 What are some of the most promising potential, high-growth opportunities for the global primary cell market by origin (hematopoietic cells, skin cells, gastrointestinal cells, liver cells, lung cells, renal cells, heart cells, skeletal & muscle cells, and other primary cells), type (human primary cells and animal primary cells), end user (life science research companies and research institutes), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global primary cell market?
Q.5 What are the business risks and threats to the global primary cell market?
Q.6 What are the emerging trends in this primary cell market and the reasons behind them?
Q.7 What are some changing demands of customers in this primary cell market?
Q.8 What are the new developments in this primary cell market? Which companies are leading these developments?
Q.9 Who are the major players in this primary cell market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this primary cell market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global primary cell market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Origin (Hematopoietic Cells, Skin Cells, Gastrointestinal Cells, Liver Cells, Lung Cells, Renal Cells, Heart Cells, Skeletal & Muscle Cells, and Other Primary Cells), Type (Human Primary Cells and Animal Primary Cells), and End User (Life Science Researcharmacogenetics, and Other Applications)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Primary Cell Market Trends and Forecast
3.3: Global Primary Cell Market by Origin
3.3.1: Hematopoietic Cells
3.3.2: Skin Cells
3.3.3: Gastrointestinal Cells
3.3.4: Liver Cells
3.3.5: Lung Cells
3.3.6: Renal Cells
3.3.7: Heart Cells
3.3.8: Skeletal & Muscle Cells
3.3.9: Other Primary Cells
3.4: Global Primary Cell Market by Type
3.4.1: Human Primary Cells
3.4.2: Animal Primary Cells
3.5: Global Primary Cell Market by End User
3.5.1: Life Science Research Companies
3.5.2: Research Institutes
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Primary Cell Market by Region
4.2: North American Primary Cell Market
4.2.1: Market by Origin: Hematopoietic Cells, Skin Cells, Gastrointestinal Cells, Liver Cells, Lung Cells, Renal Cells, Heart Cells, Skeletal & Muscle Cells, and Other Primary Cells
4.2.2: Market by Type: Human Primary Cells and Animal Primary Cells
4.2.3: Market by End User: Life Science Research Companies and Research Institutes
4.2.4: The United States Primary Cell Market
4.2.5: The Canadian Primary Cell Market
4.2.6: The Mexican Primary Cell Market
4.3: European Primary Cell Market
4.3.1: Market by Origin: Hematopoietic Cells, Skin Cells, Gastrointestinal Cells, Liver Cells, Lung Cells, Renal Cells, Heart Cells, Skeletal & Muscle Cells, and Other Primary Cells
4.3.2: Market by Type: Human Primary Cells and Animal Primary Cells
4.3.3: Market by End User: Life Science Research Companies and Research Institutes
4.3.4: The United Kingdom Primary Cell Market
4.3.5: The Spanish Primary Cell Market
4.3.6: The German Primary Cell Market
4.3.7: The French Primary Cell Market
4.4: APAC Primary Cell Market
4.4.1: Market by Origin: Hematopoietic Cells, Skin Cells, Gastrointestinal Cells, Liver Cells, Lung Cells, Renal Cells, Heart Cells, Skeletal & Muscle Cells, and Other Primary Cells
4.4.2: Market by Type: Human Primary Cells and Animal Primary Cells
4.4.3: Market by End User: Life Science Research Companies and Research Institutes
4.4.4: The Chinese Primary Cell Market
4.4.5: The Indian Primary Cell Market
4.4.6: The Japanese Primary Cell Market
4.5: ROW Primary Cell Market
4.5.1: Market by Origin: Hematopoietic Cells, Skin Cells, Gastrointestinal Cells, Liver Cells, Lung Cells, Renal Cells, Heart Cells, Skeletal & Muscle Cells, and Other Primary Cells
4.5.2: Market by Type: Human Primary Cells and Animal Primary Cells
4.5.3: Market by End User: Life Science Research Companies and Research Institutes
4.5.4: Brazilian Primary Cell Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Primary Cell Market by Origin
7.1.2: Growth Opportunities for the Global Primary Cell Market by Type
7.1.3: Growth Opportunities for the Global Primary Cell Market by End User
7.1.4: Growth Opportunities for the Global Primary Cell Market by Region
7.2: Emerging Trends in the Global Primary Cell Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Primary Cell Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Primary Cells Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Therm Fisher Scientific
8.2: Merck KGaA
8.3: Lonza
8.4: Cell Biologics
8.5: PromoCell
8.6: ZenBi
8.7: STEMCELL Technologies
8.8: AllCells
8.9: American Type Culture Collection
8.10: Axol Biosciences
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Primary Cell Market Trends and Forecast
3.3: Global Primary Cell Market by Origin
3.3.1: Hematopoietic Cells
3.3.2: Skin Cells
3.3.3: Gastrointestinal Cells
3.3.4: Liver Cells
3.3.5: Lung Cells
3.3.6: Renal Cells
3.3.7: Heart Cells
3.3.8: Skeletal & Muscle Cells
3.3.9: Other Primary Cells
3.4: Global Primary Cell Market by Type
3.4.1: Human Primary Cells
3.4.2: Animal Primary Cells
3.5: Global Primary Cell Market by End User
3.5.1: Life Science Research Companies
3.5.2: Research Institutes
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Primary Cell Market by Region
4.2: North American Primary Cell Market
4.2.1: Market by Origin: Hematopoietic Cells, Skin Cells, Gastrointestinal Cells, Liver Cells, Lung Cells, Renal Cells, Heart Cells, Skeletal & Muscle Cells, and Other Primary Cells
4.2.2: Market by Type: Human Primary Cells and Animal Primary Cells
4.2.3: Market by End User: Life Science Research Companies and Research Institutes
4.2.4: The United States Primary Cell Market
4.2.5: The Canadian Primary Cell Market
4.2.6: The Mexican Primary Cell Market
4.3: European Primary Cell Market
4.3.1: Market by Origin: Hematopoietic Cells, Skin Cells, Gastrointestinal Cells, Liver Cells, Lung Cells, Renal Cells, Heart Cells, Skeletal & Muscle Cells, and Other Primary Cells
4.3.2: Market by Type: Human Primary Cells and Animal Primary Cells
4.3.3: Market by End User: Life Science Research Companies and Research Institutes
4.3.4: The United Kingdom Primary Cell Market
4.3.5: The Spanish Primary Cell Market
4.3.6: The German Primary Cell Market
4.3.7: The French Primary Cell Market
4.4: APAC Primary Cell Market
4.4.1: Market by Origin: Hematopoietic Cells, Skin Cells, Gastrointestinal Cells, Liver Cells, Lung Cells, Renal Cells, Heart Cells, Skeletal & Muscle Cells, and Other Primary Cells
4.4.2: Market by Type: Human Primary Cells and Animal Primary Cells
4.4.3: Market by End User: Life Science Research Companies and Research Institutes
4.4.4: The Chinese Primary Cell Market
4.4.5: The Indian Primary Cell Market
4.4.6: The Japanese Primary Cell Market
4.5: ROW Primary Cell Market
4.5.1: Market by Origin: Hematopoietic Cells, Skin Cells, Gastrointestinal Cells, Liver Cells, Lung Cells, Renal Cells, Heart Cells, Skeletal & Muscle Cells, and Other Primary Cells
4.5.2: Market by Type: Human Primary Cells and Animal Primary Cells
4.5.3: Market by End User: Life Science Research Companies and Research Institutes
4.5.4: Brazilian Primary Cell Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Primary Cell Market by Origin
7.1.2: Growth Opportunities for the Global Primary Cell Market by Type
7.1.3: Growth Opportunities for the Global Primary Cell Market by End User
7.1.4: Growth Opportunities for the Global Primary Cell Market by Region
7.2: Emerging Trends in the Global Primary Cell Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Primary Cell Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Primary Cells Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Therm Fisher Scientific
8.2: Merck KGaA
8.3: Lonza
8.4: Cell Biologics
8.5: PromoCell
8.6: ZenBi
8.7: STEMCELL Technologies
8.8: AllCells
8.9: American Type Culture Collection
8.10: Axol Biosciences
